[DIOD] Diodes Incorporated


Type of security: Stock

Sector: Technology

Industry: Semiconductors

Market Capitalization: 910.54 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 26.32 Change: 0.69 (2.69%)
Ext. hours: Change: 0 (0%)

chart DIOD

Refresh chart

Strongest Trends Summary For DIOD

DIOD is in the long-term up 77% in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Diodes Incorporated, together with its subsidiaries, designs, manufactures, and supplies application specific standard products in the discrete, logic, and analog semiconductor markets primarily in Asia, North America, and Europe. The company?s discrete semiconductor products comprise performance Schottky rectifiers and diodes; Zener diodes; tight tolerance and low operating current type performance Zener diodes; standard, fast, super-fast, and ultra-fast recovery rectifiers; bridge rectifiers; switching diodes; small signal bipolar transistors; prebiased transistors; MOSFETs; thyristor surge protection devices; and transient voltage suppressors. Its analog products include power management devices, including AC-DC and DC-DC converters, USB power switches, and low dropout and linear voltage regulators; standard linear devices, such as operational amplifiers and comparators, current monitors, voltage references, and reset generators; LED lighting drivers; and sensor products comprising Hall-effect sensors and

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding48.33 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -7.63% Sales Growth - Q/Q-7.82% P/E
P/E To EPS Growth P/S1.03 P/BV1.17 Price/Cash Per Share3.66
Price/Free Cash Flow11.9 ROA5.5% ROE8.28% ROI6.61%
Current Ratio4.32 Quick Ratio3.11 Long Term Debt/Equity0.23 Debt Ratio0.2
Gross Margin31.53% Operating Margin9.82% Net Profit Margin7.29% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-17.61 M Cash From Investing Activities-38.18 M Cash From Operating Activities38.57 M Gross Profit63.91 M
Net Profit11.13 M Operating Profit16.9 M Total Assets1.18 B Total Current Assets671.6 M
Total Current Liabilities155.55 M Total Debt118.71 M Total Liabilities394.76 M Total Revenue206.18 M
Technical Data
High 52 week43.29 Low 52 week27.87 Last close37.65 Last change-1.49%
RSI44.9 Average true range1.84 Beta1.27 Volume217.38 K
Simple moving average 20 days-5.09% Simple moving average 50 days3.21% Simple moving average 200 days6.8%
Performance Data
Performance Week-5.26% Performance Month6.81% Performance Quart-0.42% Performance Half7.33%
Performance Year-1.65% Performance Year-to-date16.71% Volatility daily2.9% Volatility weekly6.48%
Volatility monthly13.29% Volatility yearly46.02% Relative Volume333.91% Average Volume467.55 K
New High0.11% New Low


2020-05-27 17:41:10 | Gilead’s Remdesivir May Be a Coronavirus Silver Bullet — But It’s Already Baked in the Stock Price

2020-05-27 16:29:55 | Gilead study shows shorter 5-day course of remdesivir works as well as 10-day one

2020-05-27 10:14:00 | MIPI 2:1 Switch from Diodes Incorporated Offers Cost-Effective Support for Multi-Camera Devices

2020-05-27 09:02:00 | Gilead Sciences Stock Is Moving Back Into Favor. It’s ‘Particularly Inexpensive.’

2020-05-27 07:33:00 | Gilead to develop immuno-oncology drugs with Arcus

2020-05-27 07:11:00 | Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies

2020-05-26 13:47:09 | Coronavirus update: Novavax begins vaccine trials; Brazil reports second-highest number of cases in world

2020-05-26 13:10:38 | Hedge Funds Piled Into Gilead Sciences, Inc. GILD During The Crash

2020-05-26 12:41:00 | Gilead Could Sell $1.1 Billion of Remdesivir This Year, Analyst Writes

2020-05-26 12:09:22 | UK's Hancock says Remdesivir may be biggest step forward in COVID-19 treatment yet

2020-05-26 10:13:00 | Merck Dives Into Covid-19 Fray With Two Vaccines and One Antiviral

2020-05-26 06:45:00 | Merck leaps into COVID-19 development fray with vaccine, drug deals

2020-05-24 07:57:33 | Gilead’s Remdesivir Most ‘Beneficial’ In Covid-19 Patients Who Need Extra Oxygen, Study Shows

2020-05-24 03:12:12 | Economic Calendar - Top 5 Things to Watch This Week

2020-05-23 14:06:00 | New Data Show Gilead’s Covid-19 Treatment Works Better on Certain Coronavirus Patients

2020-05-23 09:15:25 | Some wellness products growing ‘over 1,000%’ during pandemic: Ro CEO

2020-05-22 21:37:56 | New York Eases Ban, China Reports No New Cases: Virus Update

2020-05-22 19:15:00 | Gilead's remdesivir improves time to recovery for COVID-19 patients in peer-reviewed results, NIAID says

2020-05-22 19:15:00 | Gilead's remdesivir improves time to recovery for COVID-19 patients in peer-reviewed results, NIAID says

2020-05-22 18:34:15 | Peer-reviewed data shows Gilead's drug effective against COVID-19 -NIH

2020-05-22 16:26:27 | Coronavirus latest: Friday, May 22

2020-05-22 11:01:30 | Remdesivir Can’t Cure Covid, But Good Luck Telling Gilead Stock

2020-05-22 09:52:27 | Gilead Stock Is Worth Owning With or Without a Coronavirus Cure

2020-05-22 09:22:37 | The race for a coronavirus treatment is fanning fears of 'vaccine nationalism'

2020-05-22 07:46:27 | Telehealth is going to 'become the default' for patients: Ro CEO

2020-05-21 17:08:38 | U.S. doctors call for remdesivir data to guide coronavirus treatment

2020-05-21 15:48:12 | Fmr. CDC Official: 'we’re not cutting any corners' on COVID-19 vaccine development

2020-05-21 10:14:00 | Power Block MOSFET from Diodes Incorporated Increases Power Converter Efficiency and Saves PCB Space

2020-05-21 09:00:00 | Diodes Incorporated to Participate at Upcoming Virtual Financial Conferences

2020-05-21 02:37:12 | Gilead and Galapagos Score Positive Topline Results For Ulcerative Colitis Trial

2020-05-20 17:57:57 | Gilead Still Holds the Winning Hand, Says 5-Star Analyst

2020-05-20 16:38:52 | Gilead-Galapagos's drug meets main goals of ulcerative colitis study

2020-05-20 16:03:00 | Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis

2020-05-20 11:52:53 | Sorrento Therapeutics CEO: We are not a 'pump and dump' scheme

2020-05-19 11:58:00 | Can hydroxychloroquine prevent a COVID-19 infection? That’s Trump’s hope, it appears — and it is being looked into by researchers

2020-05-19 10:14:00 | Industry-First, Automotive-Compliant ReDriver from Diodes Incorporated Enables DisplayPort via USB Type-C

2020-05-19 08:41:00 | Covid’s Rising Costs at Retailers and 5 More Things to Know

2020-05-19 08:37:14 | Those Who Purchased Gilead Sciences NASDAQ:GILD Shares Five Years Ago Have A 32% Loss To Show For It

2020-05-18 17:28:32 | Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry

2020-05-18 15:42:05 | Coronavirus update: Moderna targets vaccine approval by year's end as reopenings continue

2020-05-18 07:27:36 | Europe Could Conditionally Approve Gilead’s Remdesivir In Next Few Days

2020-05-18 07:00:00 | 21 Cheap Stocks With Above-Average Growth Prospects

2020-05-17 07:01:00 | A Smart Pension Manager Sold Apple, GE and Gilead Stock. Here’s What It Bought.

2020-05-16 08:56:38 | Is Diodes Incorporated’s NASDAQ:DIOD 12% ROCE Any Good?

2020-05-15 16:04:42 | Why optimism over a coronavirus vaccine might be misplaced

2020-05-15 15:51:56 | Gilead to end coronavirus drug trials, adding to access worry -researchers

2020-05-15 15:09:10 | Trump unveils vaccine effort, says country will be back on its feet with or without one

2020-05-15 14:52:00 | Coronavirus update: New outbreaks reported in states that plan to reopen soon as Trump says testing ‘overrated

2020-05-15 08:52:43 | Pakistan's Ferozsons to begin producing COVID-19 drug remdesivir

2020-05-15 07:00:34 | Lessons from a Quarter We'd Like to Forget